Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (221-230 of 419) with videos related to

Pageof 42
Sort By:
Antiviral Therapy|October 26, 2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in AfricaWolfgang Stöhr, Andrew Reid, A Sarah Walker, et al.
AIDS (London, England)|June 1, 1997
Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and IrelandD M Gibb, S E MacDonagh, P A Tookey, et al.
The Lancet. Child & Adolescent Health|April 28, 2022
Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysisCatherine J Wedderburn, Ella Weldon, Cesc Bertran-Cobo, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
Journal of Gastroenterology and Hepatology|August 19, 2009
Trunk strength and mobility changes in children with slow transit constipationJanet W Chase, Barry C Stillman, Susan M Gibb, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
The Pediatric Infectious Disease Journal|May 29, 2010
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta, Deborah Ford, Veronica Mulenga, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Pageof 42

Showing results (221-230 of 419) with videos related to

Sort By:
Pageof 42
Antiviral Therapy|October 26, 2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in AfricaWolfgang Stöhr, Andrew Reid, A Sarah Walker, et al.
AIDS (London, England)|June 1, 1997
Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and IrelandD M Gibb, S E MacDonagh, P A Tookey, et al.
The Lancet. Child & Adolescent Health|April 28, 2022
Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysisCatherine J Wedderburn, Ella Weldon, Cesc Bertran-Cobo, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
Journal of Gastroenterology and Hepatology|August 19, 2009
Trunk strength and mobility changes in children with slow transit constipationJanet W Chase, Barry C Stillman, Susan M Gibb, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
The Pediatric Infectious Disease Journal|May 29, 2010
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta, Deborah Ford, Veronica Mulenga, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Pageof 42